What Clinicians, Pharmacists, and Public Health Partners Need to Know about Antibiotic Prescribing and COVID-19
“This content and conclusions are those of the author and presenter and do not necessarily represent the views of, nor should any endorsements be inferred by, the Centers for Disease Control and Prevention. ”
The fully captioned video and edited transcript will be posted within the next few days.
This COCA Call will be held on Friday, March 27, 2020
The Centers for Disease Control and Prevention (CDC) has published several studies characterizing antibiotic prescribing during the COVID-19 pandemic in outpatient, nursing home, and hospital settings. Findings from these studies and others inform opportunities to improve antibiotic use and guide the development of resources to support healthcare professionals and health systems. Case studies representing common clinical scenarios will be discussed to support decisions related to antibiotic prescribing.
During this COCA Call, clinicians, pharmacists, and public health partners will learn about the impact of the COVID-19 pandemic on antibiotic prescribing and strategies for optimizing antibiotic prescribing.
Lauri Hicks, DO
CAPT, U.S. Public Health Service
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Christopher Evans, PharmD
Healthcare Associated Infections and
Antimicrobial Resistance Program
Tennessee Department of Health
Jeffrey Gerber, MD, PhD
Associate Professor of Pediatrics and Epidemiology
University of Pennsylvania School of Medicine
Division of Infectious Diseases
Children’s Hospital of Philadelphia
Payal Patel, MD, MPH
Assistant Professor, Division of Infectious Diseases,
University of Michigan Health System
Medical Director of Antimicrobial Stewardship,
VA Ann Arbor Healthcare System
Due to the high demand we anticipate for this COCA Call, we encourage participants to consider viewing on Facebook. To see the call live, please click on COCA’s Facebook Page.
Thursday, November 18, 2021,
2:00 PM – 3:00 PM ET
US: +1 669 254 5252
or +1 646 828 7666
or +1 669 216 1590
or +1 551 285 1373
US: +16692545252,,1602924315#,,,,*875658# or +16468287666,,1602924315#,,,,*875658#
Webinar ID: 160 292 4315Add to Calendar
Registration is not required.
Date: Thursday, November 18, 2021
Time: 2:00 PM – 3:00 PM ET
A few minutes before the webinar begins, please click the link below to join:
Webinar ID: 160 292 4315
Dial-in US: +1 669 254 5252 or +1 646 828 7666 or +1 669 216 1590 or +1 551 285 1373
One-tap mobile: US: +16692545252,,1602924315#,,,,*875658# or +16468287666,,1602924315#,,,,*875658#
International numbers available: https://www.zoomgov.com/u/aCdM0lDRqexternal icon
- Describe the impact of the COVID-19 pandemic on antibiotic prescribing.
- Discuss opportunities to improve antibiotic prescribing for patients who have COVID-19.
- Identify strategies and resources to support antibiotic prescribing decisions and educate patients about appropriate antibiotic use.
COCA Call Objectives
- Cite background information on the topic covered during the presentation.
- Discuss CDC’s role in the topic covered during the presentation.
- Describe the topic’s implications for clinicians.
- Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
- Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.
None at this time
To receive continuing education (CE) for WC2922-111821 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – What Clinicians, Pharmacists, and Public Health Partners Need to Know about Antibiotic Prescribing and COVID-19, Thursday, November 18, 2021, please visit TCEO and follow these 9 Simple Steps by Monday, December 20, 2021.
To receive continuing education (CE) for WD2922-111821 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – What Clinicians, Pharmacists, and Public Health Partners Need to Know about Antibiotic Prescribing and COVID-19, Thursday, November 18, 2021 (Web on Demand), please visit TCEO and follow these 9 Simple Steps between Tuesday, December 21, 2021 and Thursday, December 21, 2023.
CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 1.0 contact hour.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1 Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.
CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
This program is a designated event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-21-243-L04-P and enduring JA4008229-0000-21-244-H04-P course category.
This program has been designated knowledge based.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
CPH: The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credits for this program.
AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at email@example.com if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters.
Planners have reviewed content to ensure there is no bias.
The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use, except Dr. Lauri Hicks would like to disclose that she will be advising against using medications that are not supported by data or recommended for treating COVID-19 (e.g. hydroxychloroquine).
CDC did not accept commercial support for this continuing education activity.
- Physician Assistants
- Health Educators
- Other Clinicians
- Contact Information:firstname.lastname@example.org
- Support/Funding:Centers for Disease Control and Prevention, Emergency Risk Communication Branch
- Method of Participation:You may participate in the educational activity by viewing the program information above.